EDIT

#3270
Editas Medicine, Inc. Common Stock
3.39 USD
+5.94%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
3.39
3.39
年范围
1.23
4.54
日变化
+5.94%
每月变动
+37.80%
6个月变化
-7.88%
年变化
+160.77%
前一天收盘价
3.20
开盘价
3.39
买价
卖价
最低价
3.39
High
3.39
交易量
60
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 331.79 M
  • Employee 87
  • Founded N/A
  • CEO N/A
  • Website www.editasmedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG005MX5GZ2
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-1.14
市销率
4.49

Editas Medicine Inc

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

新闻